| |
|
|
|
Clearside Biomedical Inc.  
|
|
1.94 -0.06 (-0.03%) |
07-02 16:00 |
|
Open: |
1.99 |
Pre close: |
2 |
Target:
|
2.65
|
|
High: |
2.02 |
Low: |
1.93 |
Resistance:
|
2.27
2.55
|
|
Volume: |
109,728 |
Market Cap: |
105M |
Support:
|
1.81
1.51
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.94
 |
MACD |
MACD(12,26):
|
-0.02  |
|
MA(20): |
2.01 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
2.05 |
Stochastic Oscillator |
%K(14,3):
|
30.66 |
|
MA(250): |
1.70 |
%D(3): |
21.32 |
|
Average Volume(K) |
3-Month: |
42867
|
52-Week |
High:
|
4.13 |
|
10-Days: |
27185 |
Low: |
0.56 |
|
RSI |
RSI(14):
|
47.05 |
Change(%): |
78.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.448 |
Return on Equity (ttm) |
-137.8 |
Shares Out. (M) |
54.31 |
|
EPS Est. Current Year |
-2.100 |
Return on Assets (ttm) |
-35.6 |
Shares Float (M) |
29.76 |
|
EPS Est. Next Year |
-2.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.36 |
|
EPS Est. Next Quarter |
-0.590 |
Qtrly Rev. Growth |
9004.4 |
% Held by Institutions |
35.21 |
|
Forward EPS |
-0.810 |
Gross Profit (p.s.) |
0.040 |
Shares Short (K) |
1580 |
|
Book Value (p.s.) |
0.230 |
EBITDA (p.s.) |
-0.325 |
P/E |
-4.33 |
|
Sales Per Share |
0.115 |
Qtrly Earnings Growth |
0.00 |
P/BV |
8.43 |
|
Profit Margin |
-293.61 |
Operating Cash Flow
(M) |
-17.22 |
P/S |
16.94 |
|
Operating Margin |
-286.49 |
Levered Free Cash Flow
(M) |
-10.70 |
P/CF |
-6.12 |
|
|
|
|
|
|
